Trade OPTIMIZERx - OPRX CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.07 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026235% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.004012% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
OPTIMIZERx Corp ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 9.47 |
Open* | 9.35 |
1-Year Change* | -55.58% |
Day's Range* | 9.35 - 9.97 |
52 wk Range | 6.92-21.27 |
Average Volume (10 days) | 161.37K |
Average Volume (3 months) | 3.86M |
Market Cap | 176.44M |
P/E Ratio | -100.00K |
Shares Outstanding | 18.15M |
Revenue | 62.81M |
EPS | -0.81 |
Dividend (Yield %) | N/A |
Beta | 1.05 |
Next Earnings Date | Feb 21, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 1, 2023 | 9.92 | 0.68 | 7.36% | 9.24 | 9.99 | 9.24 |
Nov 30, 2023 | 9.47 | 0.08 | 0.85% | 9.39 | 9.68 | 9.27 |
Nov 29, 2023 | 9.55 | 0.17 | 1.81% | 9.38 | 9.70 | 9.27 |
Nov 28, 2023 | 9.31 | -0.14 | -1.48% | 9.45 | 9.45 | 9.14 |
Nov 27, 2023 | 9.43 | -0.25 | -2.58% | 9.68 | 9.71 | 9.37 |
Nov 24, 2023 | 9.59 | -0.08 | -0.83% | 9.67 | 9.89 | 9.59 |
Nov 22, 2023 | 9.70 | 0.04 | 0.41% | 9.66 | 9.86 | 9.66 |
Nov 21, 2023 | 9.68 | -0.01 | -0.10% | 9.69 | 10.02 | 9.68 |
Nov 20, 2023 | 9.98 | 0.56 | 5.94% | 9.42 | 10.09 | 9.42 |
Nov 17, 2023 | 9.85 | 0.37 | 3.90% | 9.48 | 9.86 | 9.48 |
Nov 16, 2023 | 9.84 | 0.54 | 5.81% | 9.30 | 9.90 | 9.25 |
Nov 15, 2023 | 9.61 | 0.44 | 4.80% | 9.17 | 9.63 | 9.17 |
Nov 14, 2023 | 9.41 | 0.41 | 4.56% | 9.00 | 9.47 | 8.98 |
Nov 13, 2023 | 8.84 | -0.05 | -0.56% | 8.89 | 8.98 | 8.66 |
Nov 10, 2023 | 9.09 | 0.35 | 4.00% | 8.74 | 9.27 | 8.74 |
Nov 9, 2023 | 8.96 | 0.21 | 2.40% | 8.75 | 9.10 | 8.71 |
Nov 8, 2023 | 9.19 | -0.23 | -2.44% | 9.42 | 9.48 | 8.97 |
Nov 7, 2023 | 9.65 | 0.26 | 2.77% | 9.39 | 9.72 | 9.07 |
Nov 6, 2023 | 9.76 | -0.72 | -6.87% | 10.48 | 10.48 | 9.48 |
Nov 3, 2023 | 8.47 | 0.24 | 2.92% | 8.23 | 8.60 | 8.23 |
OPTIMIZERx Events
Time (UTC) | Country | Event |
---|---|---|
Wednesday, February 21, 2024 | ||
Time (UTC) 13:30 | Country US
| Event Q4 2023 OPTIMIZERx Corp Earnings Release Q4 2023 OPTIMIZERx Corp Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 62.4502 | 61.2926 | 43.3133 | 24.5983 | 21.2064 |
Revenue | 62.4502 | 61.2926 | 43.3133 | 24.5983 | 21.2064 |
Cost of Revenue, Total | 23.4833 | 25.6544 | 19.2079 | 9.1587 | 8.99967 |
Gross Profit | 38.9668 | 35.6382 | 24.1054 | 15.4396 | 12.2067 |
Total Operating Expense | 74.7409 | 60.9315 | 45.4486 | 28.2918 | 21.0262 |
Selling/General/Admin. Expenses, Total | 49.2355 | 33.1907 | 23.0837 | 17.8503 | 10.1812 |
Research & Development | 1.08114 | 1.41583 | |||
Depreciation / Amortization | 2.02203 | 2.08645 | 2.07589 | 1.28279 | 0.3165 |
Unusual Expense (Income) | |||||
Other Operating Expenses, Total | 0.11306 | ||||
Operating Income | -12.2907 | 0.3611 | -2.13532 | -3.69357 | 0.18013 |
Interest Income (Expense), Net Non-Operating | 0.8523 | 0.01698 | 0.06858 | 0.28803 | 0.04621 |
Net Income Before Taxes | -11.4384 | 0.37808 | -2.20713 | -4.04054 | 0.22634 |
Net Income After Taxes | -11.4384 | 0.37808 | -2.20713 | -3.14258 | 0.22634 |
Net Income Before Extra. Items | -11.4384 | 0.37808 | -2.20713 | -3.14258 | 0.22634 |
Net Income | -11.4384 | 0.37808 | -2.20713 | -3.14258 | 0.22634 |
Income Available to Common Excl. Extra. Items | -11.4384 | 0.37808 | -2.20713 | -3.14258 | 0.22634 |
Income Available to Common Incl. Extra. Items | -11.4384 | 0.37808 | -2.20713 | -3.14258 | 0.22634 |
Diluted Net Income | -11.4384 | 0.37808 | -2.20713 | -3.14258 | 0.22634 |
Diluted Weighted Average Shares | 17.784 | 17.6905 | 14.8279 | 13.3879 | 11.863 |
Diluted EPS Excluding Extraordinary Items | -0.64319 | 0.02137 | -0.14885 | -0.23473 | 0.01908 |
Diluted Normalized EPS | -0.64319 | 0.02137 | -0.14885 | -0.23473 | 0.01908 |
Other, Net | 0 | -0.14039 | -0.635 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 13.8182 | 13.0029 | 19.6545 | 15.0855 | 13.9787 |
Revenue | 13.8182 | 13.0029 | 19.6545 | 15.0855 | 13.9787 |
Cost of Revenue, Total | 5.99315 | 5.56962 | 7.20003 | 5.66473 | 4.98872 |
Gross Profit | 7.82502 | 7.43329 | 12.4544 | 9.42077 | 8.98995 |
Total Operating Expense | 18.7 | 20.0661 | 20.5188 | 18.8423 | 17.8872 |
Selling/General/Admin. Expenses, Total | 12.2421 | 14.0325 | 26.6731 | 12.6617 | 12.3204 |
Depreciation / Amortization | 0.46476 | 0.46393 | 0.45655 | 0.51583 | 0.57812 |
Other Operating Expenses, Total | -13.8109 | ||||
Operating Income | -4.88186 | -7.06319 | -0.86435 | -3.75676 | -3.90853 |
Interest Income (Expense), Net Non-Operating | 0.72042 | 0.66547 | 0.53851 | 0.28997 | 0.02382 |
Net Income Before Taxes | -4.16145 | -6.39771 | -0.32584 | -3.46679 | -3.88471 |
Net Income After Taxes | -4.16145 | -6.39771 | -0.32584 | -3.46679 | -3.88471 |
Net Income Before Extra. Items | -4.16145 | -6.39771 | -0.32584 | -3.46679 | -3.88471 |
Net Income | -4.16145 | -6.39771 | -0.32584 | -3.46679 | -3.88471 |
Income Available to Common Excl. Extra. Items | -4.16145 | -6.39771 | -0.32584 | -3.46679 | -3.88471 |
Income Available to Common Incl. Extra. Items | -4.16145 | -6.39771 | -0.32584 | -3.46679 | -3.88471 |
Diluted Net Income | -4.16145 | -6.39771 | -0.32584 | -3.46679 | -3.88471 |
Diluted Weighted Average Shares | 16.9921 | 17.0947 | 17.1531 | 17.9812 | 18.1225 |
Diluted EPS Excluding Extraordinary Items | -0.2449 | -0.37425 | -0.019 | -0.1928 | -0.21436 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.2449 | -0.37425 | -0.019 | -0.1928 | -0.21436 |
Other, Net |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 98.5766 | 115.113 | 32.8591 | 27.1418 | 15.732 |
Cash and Short Term Investments | 74.1405 | 84.6818 | 10.5168 | 18.8527 | 8.91403 |
Cash & Equivalents | 18.2087 | 84.6818 | 10.5168 | 18.8527 | 8.91403 |
Total Receivables, Net | 22.1553 | 24.8006 | 17.8857 | 7.41803 | 6.45784 |
Accounts Receivable - Trade, Net | 22.1553 | 24.8006 | 17.8857 | 7.41803 | 6.45784 |
Prepaid Expenses | 2.28083 | 5.63066 | 4.45661 | 0.87104 | 0.36015 |
Total Assets | 134.651 | 140.985 | 60.3278 | 56.6385 | 25.0546 |
Property/Plant/Equipment, Total - Net | 0.37277 | 0.47264 | 0.59483 | 0.73588 | 0.14933 |
Property/Plant/Equipment, Total - Gross | 0.50429 | 0.79699 | 0.81389 | 0.88479 | |
Accumulated Depreciation, Total | -0.13152 | -0.32435 | -0.21906 | -0.14892 | |
Intangibles, Net | 13.0229 | 10.6467 | 12.1209 | 13.9401 | 5.25907 |
Other Long Term Assets, Total | 0.00505 | 0.01286 | 0.01286 | 0.08073 | 0.23565 |
Total Current Liabilities | 8.39588 | 9.36875 | 10.0283 | 6.10751 | 4.23113 |
Accounts Payable | 1.54998 | 0.60681 | 0.61825 | 0.493 | 0.41101 |
Accrued Expenses | 2.69115 | 2.99382 | 2.54358 | 1.91607 | 1.30088 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 4.15475 | 5.76812 | 6.86648 | 3.69845 | 2.51924 |
Total Liabilities | 8.54041 | 9.60548 | 10.3538 | 11.7763 | 6.59613 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Equity | 126.111 | 131.38 | 49.9739 | 44.8623 | 18.4585 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | ||
Common Stock | 0.01829 | 0.01786 | 0.01522 | 0.0146 | 0.01204 |
Additional Paid-In Capital | 172.786 | 166.616 | 85.5904 | 78.2723 | 48.7252 |
Retained Earnings (Accumulated Deficit) | -46.6921 | -35.2537 | -35.6317 | -33.4246 | -30.2788 |
ESOP Debt Guarantee | |||||
Other Equity, Total | |||||
Total Liabilities & Shareholders’ Equity | 134.651 | 140.985 | 60.3278 | 56.6385 | 25.0546 |
Total Common Shares Outstanding | 17.0742 | 17.861 | 15.2233 | 14.6006 | 12.0386 |
Goodwill, Net | 22.6738 | 14.74 | 14.74 | 14.74 | 3.67851 |
Other Liabilities, Total | 0.14453 | 0.23673 | 0.32553 | 5.66875 | 2.365 |
Short Term Investments | 55.9318 | ||||
Treasury Stock - Common | -0.00121 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 87.3897 | 85.074 | 95.8814 | 98.5766 | 99.3346 |
Cash and Short Term Investments | 63.542 | 62.7402 | 73.7019 | 74.1405 | 78.7979 |
Cash & Equivalents | 9.92148 | 9.80833 | 16.4437 | 18.2087 | 41.329 |
Total Receivables, Net | 20.8388 | 18.2811 | 18.1647 | 22.1553 | 17.8137 |
Accounts Receivable - Trade, Net | 20.8388 | 18.2811 | 18.1647 | 22.1553 | 17.8137 |
Prepaid Expenses | 3.00886 | 4.05273 | 4.01485 | 2.28083 | 2.72299 |
Total Assets | 123.929 | 121.325 | 131.693 | 134.651 | 135.873 |
Property/Plant/Equipment, Total - Net | 0.29795 | 0.15551 | 0.35725 | 0.37277 | 0.39925 |
Goodwill, Net | 22.6738 | 22.6738 | 22.6738 | 22.6738 | 22.6738 |
Intangibles, Net | 12.4677 | 13.4215 | 12.78 | 13.0229 | 13.4529 |
Other Long Term Assets, Total | 1.1 | 0.00505 | 0.01286 | ||
Total Current Liabilities | 7.70154 | 5.50972 | 7.60554 | 8.39588 | 6.13447 |
Accounts Payable | 0.69116 | 0.81778 | 1.28885 | 1.54998 | 1.00063 |
Accrued Expenses | 3.1366 | 1.51802 | 2.21406 | 2.69115 | 1.78701 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 3.87378 | 3.17391 | 4.10262 | 4.15475 | 3.34684 |
Total Liabilities | 7.82249 | 5.50972 | 7.72877 | 8.54041 | 6.30122 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 0.12096 | 0 | 0.12323 | 0.14453 | 0.16675 |
Total Equity | 116.107 | 115.815 | 123.964 | 126.111 | 129.572 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | ||
Common Stock | 0.01839 | 0.01838 | 0.01833 | 0.01829 | 0.01826 |
Additional Paid-In Capital | 176.207 | 173.05 | 177.036 | 172.786 | 175.921 |
Retained Earnings (Accumulated Deficit) | -60.1166 | -57.2513 | -53.0898 | -46.6921 | -46.3663 |
Total Liabilities & Shareholders’ Equity | 123.929 | 121.325 | 131.693 | 134.651 | 135.873 |
Total Common Shares Outstanding | 16.6455 | 16.6354 | 17.1171 | 17.0742 | 17.5551 |
Treasury Stock - Common | -0.00174 | -0.00174 | -0.00121 | -0.00121 | -0.00071 |
Short Term Investments | 53.6206 | 52.9318 | 57.2582 | 55.9318 | 37.4689 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -11.4384 | 0.37808 | -2.20713 | -3.14258 | 0.22634 |
Cash From Operating Activities | 10.6541 | 0.72604 | -6.31039 | -1.6608 | 0.79256 |
Cash From Operating Activities | 2.02203 | 1.96533 | 1.97108 | 1.17513 | 0.3165 |
Non-Cash Items | 16.1093 | 5.69309 | 3.61804 | 2.18499 | 2.52325 |
Cash Taxes Paid | 0 | 0 | 0 | 0 | 0 |
Cash Interest Paid | 0 | 0 | 0 | 0 | 0 |
Changes in Working Capital | 3.96116 | -7.31045 | -9.69238 | -1.87835 | -2.27354 |
Cash From Investing Activities | -58.1764 | -0.486 | -0.12473 | -10.5821 | -5.68683 |
Capital Expenditures | -0.24274 | -0.46449 | -0.12473 | -1.58772 | -0.09101 |
Other Investing Cash Flow Items, Total | -57.9337 | -0.02151 | 0 | -8.99437 | -5.59582 |
Cash From Financing Activities | -18.9508 | 73.9249 | -1.90079 | 22.1815 | 8.68574 |
Issuance (Retirement) of Stock, Net | -18.9508 | 75.5358 | 2.48839 | 22.1815 | 8.68574 |
Net Change in Cash | -66.4731 | 74.165 | -8.3359 | 9.93865 | 3.79146 |
Financing Cash Flow Items | 0 | -1.61081 | -4.38919 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -6.39771 | -11.4384 | -11.1126 | -7.64581 | -3.7611 |
Cash From Operating Activities | -0.08633 | 10.6541 | 7.85059 | 4.38837 | 4.08024 |
Cash From Operating Activities | 0.46393 | 2.02203 | 1.56548 | 1.04966 | 0.47154 |
Non-Cash Items | 4.50868 | 16.1093 | 11.6094 | 7.29815 | 3.1951 |
Changes in Working Capital | 1.33877 | 3.96116 | 5.78833 | 3.68638 | 4.17471 |
Cash From Investing Activities | -1.54889 | -58.1764 | -39.6919 | -2.18659 | -0.06575 |
Capital Expenditures | -0.22248 | -0.24274 | -0.06467 | -0.04134 | -0.01448 |
Cash From Financing Activities | -0.12979 | -18.9508 | -11.5115 | 0.50942 | 0.25813 |
Financing Cash Flow Items | -0.1704 | 0 | 0 | 0 | 0 |
Issuance (Retirement) of Stock, Net | 0.04061 | -18.9508 | -11.5115 | 0.50942 | 0.25813 |
Net Change in Cash | -1.76502 | -66.4731 | -43.3527 | 2.7112 | 4.27262 |
Cash Taxes Paid | 0 | 0 | 0 | 0 | 0 |
Cash Interest Paid | 0 | 0 | 0 | 0 | 0 |
Other Investing Cash Flow Items, Total | -1.32641 | -57.9337 | -39.6272 | -2.14526 | -0.05127 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
First Light Asset Management, LLC | Investment Advisor/Hedge Fund | 10.3515 | 1871799 | 111203 | 2023-06-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.6797 | 1027024 | 71557 | 2023-06-30 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.9215 | 889936 | 21764 | 2023-06-30 | LOW |
William Blair & Company, L.L.C. (Research) | Research Firm | 4.6775 | 845816 | 2404 | 2023-06-30 | LOW |
D. E. Shaw & Co., L.P. | Hedge Fund | 2.9641 | 535979 | 64747 | 2023-06-30 | MED |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.7213 | 492071 | 69169 | 2023-06-30 | LOW |
Federated MDTA LLC | Investment Advisor/Hedge Fund | 2.6126 | 472426 | 116597 | 2023-06-30 | HIGH |
Febbo (William J) | Individual Investor | 2.6069 | 471396 | -4 | 2023-04-12 | LOW |
Point72 Asset Management, L.P. | Hedge Fund | 2.5534 | 461716 | -14476 | 2023-06-30 | HIGH |
Wasatch Global Investors Inc | Investment Advisor/Hedge Fund | 2.5364 | 458641 | -10560 | 2023-06-30 | LOW |
AWM Investment Company, Inc. | Investment Advisor/Hedge Fund | 2.4624 | 445268 | 47025 | 2023-06-30 | LOW |
G2 Investment Partners Management LLC | Hedge Fund | 2.223 | 401982 | -134427 | 2023-06-30 | HIGH |
Rice Hall James & Associates, LLC | Investment Advisor/Hedge Fund | 2.1733 | 392994 | 29703 | 2023-06-30 | LOW |
Avenir Corporation | Investment Advisor | 2.1107 | 381660 | -32913 | 2023-06-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.8562 | 335653 | 12063 | 2023-06-30 | LOW |
Credit Suisse Funds AG | Investment Advisor/Hedge Fund | 1.7548 | 317307 | -3189 | 2023-06-30 | LOW |
Jacob Asset Management of New York, LLC | Investment Advisor | 1.574 | 284610 | 140 | 2023-06-30 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 1.443 | 260924 | 80823 | 2023-06-30 | LOW |
Two Sigma Investments, LP | Hedge Fund | 1.311 | 237062 | -64417 | 2023-06-30 | HIGH |
Kornitzer Capital Management Inc. | Investment Advisor | 1.247 | 225489 | -127505 | 2023-06-30 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
OPTIMIZERx Company profile
About OptimizeRx Corporation
OptimizeRx Corporation is a digital health technology company. The Company enables engagement between life sciences organizations, healthcare providers and patients. It connects approximately 60% of United States healthcare providers and their patients through a technology platform embedded within its own point-of-care network. The Company principal solutions and applications include financial messaging, brand therapeutic support messaging, and brand support. Its financial messaging enables doctors and staffs to access a universe of sample voucher, co-pay coupons and other patient support option through their electronic medical records (EMR) and/or e-prescribe system. Its brand messaging service includes brands awareness message, reminder advertisement, therapeutic support and unbranded messages. Its brand support is focused on educating and working with pharmaceuticals manufacturer on identifying, formulation and implementing new eRx media strategy for promoting their solutions.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, OptimizeRx Corporation revenues increased 42% to $61.3M. Net income totaled $378K vs. loss of $2.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects FV Adjustments of Financial Investments decrease from $140K (expense) to $0K.
Equity composition
.
Industry: | Online Services (NEC) |
260 Charles Street
Suite 302
WALTHAM
MASSACHUSETTS 02453
US
Income Statement
- Annual
- Quarterly
News

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023
UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?
UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.
10:48, 21 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com